Advanced Solid Tumors: BMS-986340 Treatment Study

We are testing a new treatment called BMS-986340, both alone and with other medications, for people with advanced solid tumors. The goal is to assess its safety and how well it may work against cancer.

>2 yearsSafety phase (I)Efficacy phase (II)No PlaceboInvestigational MedicinesInjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Docetaxel Ebewe
Docetaxel Ebewe is a cancer medicine used to treat several types of cancer by stopping cancer cells from growing.
Opdivo
Opdivo is a cancer medicine that helps the immune system find and fight tumor cells.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Docetaxel
Docetaxel is a chemotherapy substance used to treat various cancers by stopping cancer cells from dividing.
Nivolumab
Nivolumab is a substance that helps the immune system recognize and attack certain cancers.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Anti-Ccr8 Nf Mab
Bms-986340

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Bendadocel
Camitotic
Demotaxel

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Technische Universitat Dresden
Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC), Clinical Trial Center (CTC)
Dresden, Germany
Universitaetsklinikum Essen AöR
Innere Klinik, Westdeutsches Tumorzentrum Essen
Essen, Germany
Goethe University Frankfurt
Medizinische Klinik II, Abt. Onko./José Carreras Ambulanz f. Molek. Therapien
Frankfurt am Main, Germany
Sponsor: Bristol-Myers Squibb Services Unlimited Company
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.